Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Hammann

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|April 10, 2024
Pharmacokinetics and Pharmacodynamics of Inhaled Nicotine Salt and Free-Base Using an E-cigarette: A Randomized Crossover StudySamuel E Christen, Laura Hermann, Elias Bekka, et al.
Antibiotics (Basel, Switzerland)|October 25, 2024
Target Attainment and Population Pharmacokinetics of Cefazolin in Patients with Invasive <i>Staphylococcus aureus</i> Infections: A Prospective Cohort StudySeverin Bausch, Sarah Dräger, Panteleimon Charitos-Fragkakis, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 7, 2018
Pharmacokinetics of oxycodone/naloxone and its metabolites in patients with end-stage renal disease during and between haemodialysis sessionsAnne Leuppi-Taegtmeyer, Urs Duthaler, Felix Hammann, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 8, 2024
Mosquitocidal efficacy and pharmacokinetics of single-dose ivermectin versus three-day dose regimen for malaria vector control compared with albendazole and no treatment: An open-label randomized controlled trialYvonne Kamau, Mercy Tuwei, Caroline Wanjiku, et al.
Scientific Reports|August 19, 2017
Cytochrome P450/ABC transporter inhibition simultaneously enhances ivermectin pharmacokinetics in the mammal host and pharmacodynamics in Anopheles gambiaeCarlos J Chaccour, Felix Hammann, Marta Alustiza, et al.
Trials|October 15, 2024
UROPOT: study protocol for a randomized, double-blind phase I/II trial for metabolism-based potentiation of antimicrobial prophylaxis in the urological tractKevin Stritt, Beat Roth, Audrey Masnada, et al.
Trials|June 10, 2020
The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trialCarlos Chaccour, Paula Ruiz-Castillo, Mary-Ann Richardson, et al.
Trials|February 22, 2023
BOHEMIA: Broad One Health Endectocide-based Malaria Intervention in Africa-a phase III cluster-randomized, open-label, clinical trial to study the safety and efficacy of ivermectin mass drug administration to reduce malaria transmission in two African settingsCarlos Chaccour, Aina Casellas, Felix Hammann, et al.
Eclinicalmedicine|January 26, 2021
The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trialCarlos Chaccour, Aina Casellas, Andrés Blanco-Di Matteo, et al.
Eclinicalmedicine|November 24, 2025
Ivermectin to reduce malaria transmission- safety and efficacy results from the BOHEMIA cluster randomized trial in MozambiqueCarlos Chaccour, Patricia Nicolas, Samuel Martinho, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|April 10, 2024
Pharmacokinetics and Pharmacodynamics of Inhaled Nicotine Salt and Free-Base Using an E-cigarette: A Randomized Crossover StudySamuel E Christen, Laura Hermann, Elias Bekka, et al.
Antibiotics (Basel, Switzerland)|October 25, 2024
Target Attainment and Population Pharmacokinetics of Cefazolin in Patients with Invasive <i>Staphylococcus aureus</i> Infections: A Prospective Cohort StudySeverin Bausch, Sarah Dräger, Panteleimon Charitos-Fragkakis, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 7, 2018
Pharmacokinetics of oxycodone/naloxone and its metabolites in patients with end-stage renal disease during and between haemodialysis sessionsAnne Leuppi-Taegtmeyer, Urs Duthaler, Felix Hammann, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 8, 2024
Mosquitocidal efficacy and pharmacokinetics of single-dose ivermectin versus three-day dose regimen for malaria vector control compared with albendazole and no treatment: An open-label randomized controlled trialYvonne Kamau, Mercy Tuwei, Caroline Wanjiku, et al.
Scientific Reports|August 19, 2017
Cytochrome P450/ABC transporter inhibition simultaneously enhances ivermectin pharmacokinetics in the mammal host and pharmacodynamics in Anopheles gambiaeCarlos J Chaccour, Felix Hammann, Marta Alustiza, et al.
Trials|October 15, 2024
UROPOT: study protocol for a randomized, double-blind phase I/II trial for metabolism-based potentiation of antimicrobial prophylaxis in the urological tractKevin Stritt, Beat Roth, Audrey Masnada, et al.
Trials|June 10, 2020
The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trialCarlos Chaccour, Paula Ruiz-Castillo, Mary-Ann Richardson, et al.
Trials|February 22, 2023
BOHEMIA: Broad One Health Endectocide-based Malaria Intervention in Africa-a phase III cluster-randomized, open-label, clinical trial to study the safety and efficacy of ivermectin mass drug administration to reduce malaria transmission in two African settingsCarlos Chaccour, Aina Casellas, Felix Hammann, et al.
Eclinicalmedicine|January 26, 2021
The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trialCarlos Chaccour, Aina Casellas, Andrés Blanco-Di Matteo, et al.
Eclinicalmedicine|November 24, 2025
Ivermectin to reduce malaria transmission- safety and efficacy results from the BOHEMIA cluster randomized trial in MozambiqueCarlos Chaccour, Patricia Nicolas, Samuel Martinho, et al.
Pageof 7